Global Expansion Nemera's recent investments in expanding manufacturing facilities in France and Poland present opportunities to provide additional automation, advanced production equipment, and factory support services to enhance their capacity and operational efficiency.

Innovative Technologies The development of proprietary technologies like DriDose dry powder intranasal devices indicates a growing demand for cutting-edge drug delivery solutions, creating potential for suppliers of advanced materials, specialized manufacturing equipment, and R&D collaborations.

Strategic Partnerships Nemera’s collaborations with companies such as Therakind and initiatives to promote gender diversity suggest an openness to new partnerships and innovative co-development projects, ideal for identifying alliances in technology development and diverse supplier networks.

Regulatory & Quality Focus With a commitment to high-quality standards in device manufacturing, Nemera likely requires top-tier compliance, validation, and quality assurance services, providing opportunities for vendors offering regulatory consulting, quality management systems, and certification support.

Market positioning As a leader in drug device combination solutions with a comprehensive product portfolio across multiple delivery routes, Nemera is well-positioned to expand into emerging markets such as personalized medicine and biologics, offering prospects for specialized manufacturing and innovative device solutions tailored to evolving treatment modalities.